11:25 AM EST - Acerus Pharmaceuticals Corporation : Announced the signing of an agreement granting Apsen Farmacêutica (Apsen) the exclusive right to market NATESTO® in Brazil. Apsen is a leading Brazilian based pharmaceutical company with over 40 products and 1,100 employees in that country. Acerus Pharmaceuticals Corporation
shares T.ASP are trading up $0.045 at $0.25.
